| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
49 companies · Health Care
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 1, 2025 | NTRA Natera, Inc. | Chapman Steven Leonard | CEO And President | Sell | 5,807 | $132.88 | $771,656.35 | -1.7% | - | - | |
| Aug 1, 2025 | NTRA Natera, Inc. | Moshkevich Solomon | President, Clinicaldiagnostics | Sell | 3,000 | $132.89 | $398,657.37 | -0.8% | - | - | |
| Aug 1, 2025 | NTRA Natera, Inc. | Marcus Gail Boxer | Director | Sell | 2,496 | $133.17 | $332,394.65 | -16.4% | - | - | |
| Jul 29, 2025 | WGS Genedx Holdings Corp. | Stueland Katherine | Chief Executive Officer | Sell | 2,154 | $105.31 | $226,837.74 | -38.5% | - | - | |
| Jul 29, 2025 | WGS Genedx Holdings Corp. | Feeley Kevin | Chief Financial Officer | Sell | 388 | $105.31 | $40,860.28 | -9.4% | - | - | |
| Jul 29, 2025 | NTRA Natera, Inc. | Brophy Michael Burkes | Chief Financial Officer | Sell | 5,064 | $138.36 | $700,670.43 | -1.9% | - | - | |
| Jul 28, 2025 | NTRA Natera, Inc. | Moshkevich Solomon | President, Clinicaldiagnostics | Sell | 2,206 | $139.81 | $308,417.11 | -1.7% | - | - | |
| Jul 28, 2025 | PSNL Personalis, Inc. | Tachibana Aaron | CFO And COO | Sell | 641 | $6.57 | $4,211.37 | -0.4% | - | - | |
| Jul 28, 2025 | NTRA Natera, Inc. | Rabinowitz Matthew | Executive Chairman | Sell | 1,718 | $139.81 | $240,190.66 | - | - | - | |
| Jul 28, 2025 | PSNL Personalis, Inc. | Chen Richard | Chief Medical Officer And EVP | Sell | 452 | $6.57 | $2,969.64 | -0.4% | - | - | |
| Jul 28, 2025 | NTRA Natera, Inc. | Chapman Steven Leonard | CEO And President | Sell | 6,092 | $139.81 | $851,712.16 | -3.5% | - | - | |
| Jul 28, 2025 | NTRA Natera, Inc. | Sheena Jonathan | - | Sell | 479 | $139.81 | $66,968.18 | -0.2% | - | - | |
| Jul 28, 2025 | NTRA Natera, Inc. | Rabinowitz Daniel | Sec. And Chief Legal Officer | Sell | 1,994 | $139.81 | $278,777.75 | -1.0% | - | - | |
| Jul 28, 2025 | NTRA Natera, Inc. | Fesko John | President, Chief Bus. Officer | Sell | 1,710 | $139.81 | $239,072.19 | -1.1% | - | - | |
| Jul 28, 2025 | MEDP Medpace Holdings, Inc. | Troendle August J. | CEO | Sell | 48,487 | $451.69 | $21,901,093.03 | -4.8% | - | - | |
| Jul 28, 2025 | MEDP Medpace Holdings, Inc. | Ewald Stephen P | General Counsel &Corp. Secy. | Sell | 3,000 | $450.00 | $1,350,000.00 | -22.5% | - | - | |
| Jul 28, 2025 | MEDP Medpace Holdings, Inc. | Burwig Susan E | Exec. VP, Operations | Sell | 7,500 | $450.14 | $3,376,050.00 | -11.5% | - | - | |
| Jul 25, 2025 | TMO Thermo Fisher Scientific Inc. | Pettiti Gianluca | Executive Vice President | Sell | 400 | $479.98 | $191,992.00 | -1.8% | +19.6% | - |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.